Health, Vaccines, Lyme Disease, FDA, Medicine.
Valneva researchers decided to eliminate its epitope from their antigen to “not give any room to scientific speculation.” But as with LYMErix, targeting OspA antigens means producing enough antibodies to stop pathogen transmission. Once inside the host, Borrelia switches outer surface proteins and